Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

3
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
3
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

3
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

238
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
238
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

138
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
138

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared genetic and environmental influences between the broad avoidant/restrictive food intake disorder phenotype and neurodevelopmental traits: a twin study.

medRxiv : the preprint server for health sciences·2026
Same author

Family functioning types and self-injury risk among left-behind secondary school students: a latent profile analysis with shame as a mediator.

Frontiers in psychology·2026
Same author

Exosomes in Glioma: Integrating Molecular Mechanisms with Diagnostic and Therapeutic Potential.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Biocatalysis and biodegradation for efficient utilization of liquid n-alkanes.

Biotechnology advances·2026
Same author

Mutation in MSH5 Causes Primary Ovarian Insufficiency and Successful Therapeutic Intervention by In Vitro Fertilisation.

Journal of cellular and molecular medicine·2026
Same author

Mechanisms of weight recurrence after bariatric surgery.

Nutrition & metabolism·2026

Related Experiment Video

Updated: Jun 11, 2025

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

3.6K

Kallmann syndrome: Diagnostics and management.

Rajiv Kumar Yadav1, Baiyu Qi2, Jianping Wen2

  • 1Department of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, China; Department of Endocrinology (Internal Medicine), First Hospital of Jilin University, Changchun, Jilin 130021, China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|October 9, 2024
PubMed
Summary
This summary is machine-generated.

Kallmann syndrome, a genetic disorder causing absent puberty and smell, is linked to KAL1 gene mutations. Early diagnosis and management are key for developing secondary sexual characteristics and restoring fertility.

Keywords:
Gonadotropic-releasing hormoneHypogonadotropic hypogonadismKAL1 geneKallmann syndromePreimplantation genetic testingPrenatal diagnosis

More Related Videos

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.8K
Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
03:13

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Published on: June 28, 2024

580

Related Experiment Videos

Last Updated: Jun 11, 2025

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

3.6K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.8K
Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
03:13

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Published on: June 28, 2024

580

Area of Science:

  • Genetics
  • Endocrinology
  • Reproductive Medicine

Background:

  • Kallmann syndrome is a genetic disorder characterized by hypogonadotropic hypogonadism and anosmia.
  • It results from a deficiency in gonadotropin-releasing hormone (GnRH) production, impacting sex hormone levels and secondary sexual characteristic development.
  • The condition exhibits genetic heterogeneity, with mutations in genes like KAL1 being a known cause.

Purpose of the Study:

  • To explore genetic diagnostic and management strategies for Kallmann syndrome.
  • To focus on the role of KAL1 gene mutations in the syndrome's presentation and treatment.

Main Methods:

  • Review of recent literature on Kallmann syndrome.
  • Analysis of genetic mutations, particularly in the KAL1 gene.
  • Examination of clinical manifestations and diagnostic approaches.

Main Results:

  • Germline mutations in the KAL1 gene are identified in a subset of Kallmann syndrome patients.
  • KAL1 mutations are associated with various clinical features, including microgenitalia, impotence, reduced libido, infertility, renal agenesis, and synkinesia.
  • Genetic molecular diagnostics, such as prenatal diagnosis and preimplantation genetic testing, are crucial for risk reduction.

Conclusions:

  • Early diagnosis, nutritional support, and medical therapy can prevent complications associated with Kallmann syndrome.
  • Therapeutic goals include promoting secondary sexual development, maintaining bone and muscle mass, and restoring fertility.
  • Understanding KAL1 gene mutations is vital for effective genetic diagnosis and management of Kallmann syndrome.